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ABSTRACT
Emergence of multidrug-resistant bacteria forces us to explore new therapeutic strategies, and proteins
involved in key metabolic pathways are promising anti-bacterial targets. Bifunctional flavin-adenine
dinucleotide (FAD) synthetases (FADS) are prokaryotic enzymes that synthesise the flavin mononucleotide
(FMN) and FAD cofactors. The FADS from the human pathogen Streptococcus pneumoniae
(SpnFADS)–causative agent of pneumonia in humans shows relevant catalytic dissimilarities compared to
other FADSs. Here, by integrating thermodynamic and kinetic data, we present a global description of the
riboflavin kinase activity of SpnFADS, as well as of the inhibition mechanisms regulating this activity. Our
data shed light on biophysical determinants that modulate species-specific conformational changes leading
to catalytically competent conformations, as well as binding rates and affinities of substrates versus prod-
ucts. This knowledge paves the way for the development of tools that taking advantage of the regula-
tory dissimilarities during FMN biosynthesis in different speciesmight be used in the discovery of
specific anti-pneumococcal drugs.
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Introduction
Streptococcus pneumoniae is the causative agent of human pneu-
monia disease1, meningitis and bacteremia in children and adults.
It is estimated that 1.6 millions of people, including 1 million of
children under age five die every year of pneumonia disease2,3.
The irruption during the last decades of multi-drug resistant pneu-
mococci has revealed the need of finding new drugs, as well as
novel drug targets. The bifunctional flavin-adenine dinucleotide
(FAD) synthetase (FADS) from S. pneumoniae (SpnFADS) arises as a
potential drug target4,5, since it synthesises the essential cofactors
flavin mononucleotide (FMN) and FAD6, involved in a plethora of
vital processes as part of flavoproteins and flavoenzymes7–9. As
other bacterial FADSs, SpnFADS produces FMN and FAD through
two sequential activities. First, a riboflavin kinase activity (RFK) at
its C-terminus module phosphorylates riboflavin (RF) to FMN, and
then the adenosine 50-triphosphate (ATP):FMN:adenylyltransferase
(FMNAT) activity of the enzyme N-terminus module transforms
FMN into FAD10–12. Two characteristics stand out among the
suitable properties of FADSs as drug targets. First, bacterial FADSs
differ from the human proteins that synthesise FMN and particu-
larly FAD. Thus, the eukaryotic FMNAT activity is catalysed by an
enzyme with a completely different protein folding and chemistry
relative to the N-terminus of bacterial FADS13–16. Regarding FMN
production, the monofunctional Homo sapiens RFK has been
hardly characterised so far. Overall, it is structurally homologous to
the RFK module of bacterial enzymes, but only structures
containing bound ligands are available17,18. Nonetheless, structural
data predict differences in conformational changes to achieve the
catalytic complex19,20, and the scarce biochemical information
suggests differences in redox environmental requirements for max-
imal activity11,12. Second, the members of the prokaryotic FADSs
family studied up to now differ catalytically among them, which
might facilitate the design of new species-specific medicines.
Structurally, when comparing SpnFADS with the member of the
family so far best characterised—which is that from the organism
Corynebacterium ammoniagenes (CaFADS)—it presents a very simi-
lar structure, with little differences in the position of some key
loops. However, these two proteins only share the 26% of
sequence homology6. Despite the overall structural similitude
among prokaryotic FADSs6,12,18, SpnFADS shows three main dis-
tinctive functional behaviors; (i) it mainly stabilises monomers—
which are the functional form6—or traces of dimers, during cataly-
sis; (ii) its FMNAT activity requires reduced FMN as a substrate;
and (iii) its RFK activity is not regulated by the RF substrate6.
Here, we focus on the SpnFADS RFK activity, using pre-steady
and steady-state biophysical techniques to describe this activity
and the inhibition mechanism employed by this enzyme to regu-
late FMN synthesis. We take a close look at the thermodynamic
and kinetic basis that determine the ligand binding order, the co-
operativity between ligands and the inhibitory mechanism per-
formed by the reaction products. Furthermore, we compare our
results with those obtained for the FADS from C. ammoniagenes
to identify key regulatory differences between both proteins.
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Methods
Cloning, expression, and purification of SpnFADS
SpnFADS was cloned, overexpressed, and purified as previously
described6. In short, Escherichia coli Bl21 StarTM (DE3) cells were
transformed with a pET-15b vector that contains the DNA
sequence encoding SpnFADS. Transformed cells were grown and
protein expression induced through isopropyl b-D-1-thiogalacto-
pyranoside (IPTG) addition. Cells were harvested and broken by
sonication. The supernatant was loaded into a His-Trap affinity col-
umn and the protein eluted applying a 10–500mM imidazole gra-
dient. The His6-Tag was removed and then the protein was loaded
into HisTrap HP and GSTrap 4B connected columns. The unbound
fraction was further purified by size exclusion chromatography.
The protein purity was tested and pure protein aliquots were con-
served at 80 C.
Steady-state RFK activity
The SpnFADS RFK activity was measured at 25 C in 500 mL of
20mM 1,4-piperazinediethanesulfonic acid (PIPES) and 0.8mM
MgCl2, pH 7.0. Reaction samples contained different concentra-
tions of RF (0.5–30 mM) and ATP (10–500 mM), as previously
described21,22. The inhibitory effect of the products of the reaction
was analysed as previously described23. In short, the SpnFADS RFK
activity was determined at increasing concentrations of FMN,
varying the ATP concentration and keeping the RF constant (when
studying the inhibitory effect of FMN), and at increasing concen-
trations of adenosine 50-diphosphate (ADP), varying the RF con-
centration and keeping the ATP fixed (when studying the
inhibitory effect of ADP). The flavin composition of the super-
natant was determined using an Alliance high performance liquid
chromatography (HPLC) system (Waters, Milford, MA, USA)
equipped with a 2707 autosampler and a HSST3 column
(4.6 50mm, 3.5mm; Waters) preceded by a precolumn
(4.6 20mm, 3.5mm; Waters) as previously described21,22. The
FMN concentration was quantified using its standard curve. All the
experiments were carried out in triplicate.
Michaelis–Menten (Km) and catalytic rate (kcat) constants were
obtained by fitting the obtained data to the Michaelis equation24.
The inhibitory mechanism performed by the products of the RFK
reaction FMN and ADPwas analysed by evaluating their effects
on the Km and kcat values, obtained by the individual fitting of
data sets to the Michaelis–Menten model. Additionally, the data
sets were globally fit utilising the Lineweaver–Burk equations for
mixed inhibition25 (Equation (1)).
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where, [S] and [I] are the concentration of substrates and product
inhibitor, respectively. Ki and K’ i are the product inhibition con-
stants25. Experiments were performed in triplicate. The estimated
errors in kcat, Km, and Ki were within ±15% of their values.
Pre-steady-state kinetics
Kinetic experiments in the pre-steady state were registered as pre-
viously described23, using stopped-flow spectroscopy on an
Applied Photophysics SX17. MV spectrophotometer, using the
Xscan software (Applied Photophysics Ltd., Leatherhead, UK). Fast
kinetic measurements were carried out as previously described23,
at 25 C in PIPES 20mM pH 7.0, 0.8mM MgCl2. About 0.2mM
SpnFADS was mixed with reaction samples that contained increas-
ing concentrations of the flavin ligands (FLV, herein indicating RF
or FMN), in the presence and in the absence of ADP or ATP
(herein referred as ANP). Controls were measured in the same buf-
fer but without MgCl2. All concentrations indicated here are the
final ones in the reaction cell. The kinetic traces were registered
until obtaining three reproducible traces.
Kinetic traces were fit to exponential equations (Equation (2)),
where each exponential term describes a different process. A
linear correction term was added (Equation (3)) when a specific
process was not finished within the measuring timeframe.
y ¼
X
Aie
kobs;i :t (2)
y ¼
X
Aie
kobs;i :t þ bt (3)
where, Ai and kobs,i are the amplitude and the observed kinetic
constant for each process (i) that contributes to the overall time-
dependent fluorescence change.
The processes whose kobs showed a linear dependency on the
flavin concentration were fit to a one-step model that describes
the kinetic equilibrium for the formation and the dissociation of
enzyme-flavin complex (Equation (4))
kobs ¼ kon FLV½  þ koff (4)
where, kon and koff are the complex formation and dissociation
kinetic constants, respectively.
Experiments were performed in triplicate. The flavin photo-
bleaching was analysed as previously described23 (not shown).
Isothermal titration calorimetry
We performed isothermal titration calorimetry (ITC) assays to eluci-
date both the ligand binding order and the thermodynamic
inhibition produced by the binding of the FLV and ANP ligands.
Titrations were performed on an AutoITC200 (MicroCal, Malvern,
UK) thermostated at 20 C, as previously described23.
Approximately 25mM SpnFADS contained in a 200mL-cell was
titrated with solutions of 180 mM RF, 250 mM FMN, or 350mM ATP
or ADP. Additionally, titrations with ANP ligands into mixtures that
contain the protein pre-bound to FLV ligands were performed, as
well as titrations with FLV ligands into pre-bound SpnFADS:ANP
complexes. The titrations were conducted through 19 stepwise
injections of 2 mL of the titrating ligand to the calorimetric cell, as
previously described21,26. Both the ligands and the protein were
dissolved in 20mM PIPES, pH 7.0, either in presence of 0.8mM
MgCl2 or in absence of this cation, and degassed before the titra-
tion. The enthalpy change (DH), the association constant (Ka), and
the binding stoichiometry (N) were obtained through non-linear
least squares regression of the data using a homemade fitting rou-
tine corresponding to a model for one or two independent bind-
ing sites, implemented in Origin 7.0 (OriginLab, Northampton, MA,
USA), as previously described21,26. The Gibbs free energy (DG), the
entropic contribution (TDS), and the dissociation constant (Kd)
were obtained using well-known thermodynamic equations.
Cooperativity constants (a) between ANP and FLV ligands were
obtained as previously described23,27,28. Particular titrations with
ANP ligands into mixtures of the protein and 100mM FLV were fit
to a homemade fitting routine corresponding to a model that con-
siders the influence of the FLV ligand in the protein binding
affinity for the ANP ligand27,28.
Experiments were performed in triplicate. The errors considered
in the measured parameters (±15% in Kd and Ka values,
±0.3 kcal mol1 in DG, DH, and TDS and±20% in a) were
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assumed to be larger than the standard deviation between repli-
cates and the numerical error after fitting analysis.
Results and discussion
The products of the reaction inhibit the RFK activity of SpnFADS
Feedback inhibition is a frequent strategy to regulate enzymes
involved in key metabolic pathways29,30. Some bacteria regulate
FMN synthesis through the inhibition of the RFK activity of their
bifunctional FADSs by the reaction products–FMN and ADP–and/
or the RF substrate19,23, although the inhibition level triggered
differs between organisms6,23. Here, our Michaelis–Menten plots of
the SpnFADS RFK activity, for both reaction substrates–RF and
ATP–at increasing concentrations of the FMN and ADP products,
reveal that kcat decreases while Km
ATP and Km
FMN increase (Figure
1). These data point out to mixed or uncompetitive inhibition
mechanisms. Therefore, to discern the inhibition mechanism, we
carried out Lineweaver–Burk representations (Figure 1(B,D)), which
reveal that both products act as mixed inhibitors (Figure 1). Thus,
FMN and ADP bind to the free enzyme as well as to the
SpnFADS:ATP and SpnFADS:RF complexes, respectively. However,
their affinities for the free protein and for the complex
considerably differ (Table 1), being Ki
ADP and Ki
FMN 6.4 and 5.5
times smaller than Ki
ADP and Ki
FMN, respectively. That indicates that
both reaction products bind preferentially to the free enzyme.
Also, the considerably smaller inhibition constants for FMN com-
pared to ADP (Ki
ADP/Ki
FMN¼ 100) reveals the flavin product as a
much more potent inhibitor (Table 1).
Equivalent data obtained for the so far best characterised
FADS–that belonging to C. ammoniagenes (CaFADS)–show that
ADP and FMN are, respectively, competitive and uncompetitive
inhibitors of its RFK activity23. The FMN product appears as a con-
siderable more potent inhibitor of the RFK activity of CaFADS than
of SpnFADS, as the Km
RF/Ki
FMN values of 7.1 and 0.8 for CaFADS
and SpnFADS, respectively, show. This, together with the fact that
RF strongly inhibits the CaFADS RFK activity but not the SpnFADS
one6, points to species-specific inhibition and activity modulation
mechanisms. Physiologically, other preferred regulatory strategies,
such as the use of reduced FMN during the FMNAT activity, and
the different oligomeric assemblies established along both
activities of these enzymes6,31,32, might be also behind the distinct
requirements for the RFK activity regulation.
The binding of the substrates of the RFK reaction is the fastest
and most favored process for SpnFADS
Then we used stopped-flow spectrophotometry23,33 to kinetically
identify individual steps during the SpnFADS RFK reaction. Here,
we took advantage of two aspects; (i) RF and FMN have the same
fluorescence spectra and yields34 and (ii) under oxidising
Figure 1. Inhibition of the SpnFADS RFK reaction by FMN and ADP products. Michaelis–Menten plots as a function of (A) ATP and (C) RF substrates at different concen-
trations of the ADP and FMN products. Lineaweaver–Burk representation at different (B) ADP and (D) FMN concentrations with global fitting to the equation for
mixed inhibition.
Table 1. Steady-state kinetic parameters for the SpnFADS RFK activity as calcu-
lated by global fitting to the Lineweaver–Burk equation.
Ki
ADP
(lM)
Ki0
ADP
(lM)
kcat
(min1)
Km
ATP
(lM)
Ki
FMN
(lM)
Ki0
FMN
(lM)
Km
RF
(lM)
130 ± 16 844 ± 97 55 ± 2 75 ± 7 1.3 ± 0.4 7.1 ± 1.3 1.2 ± 0.3
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conditions flavins only bind and get transformed at the RFK
module of SpnFADS6. Consequently, although RF would be trans-
formed into FMN, we would only observe fluorescence changes
derived from flavin binding, flavin dissociation, and/or conform-
ational changes at the RFK module.
When mixing SpnFADS with RF or FMN (herein FLV) ligands, we
only observed flavin photobleaching, similarly to that reported for
CaFADS23. This suggests that SpnFADS is not able either to bind
oxidised flavins or to internalise their isoalloxazine ring. On the
contrary, fast and intense exponential flavin fluorescence variations
were observed when mixing SpnFADS simultaneously with ANP
(ATP or ADP) and FLV ligands. All samples showed fast initial
fluorescence decays, but mixtures containing ATP also presented
subsequent fluorescence increases (Figure 2(A,B)). As recently
reported for CaFADS23, we relate the initial fluorescence decay to
FLV binding and internalisation through a conformational change
of the loop-L4c, that closes the flavin binding site when ANP is
previously bound (Supplementary Figure SP1)20. The succeeding
fluorescence raise can be similarly related to an ATP-induced con-
formational change that re-opens the flavin binding site, making
the isoalloxazine ring accessible again to the solvent23 (Figure 2(C,
D), schemes). kobs1 and kobs2 represent, respectively, the observed
rates for these processes. The linear dependence of kobs1 on FLV
concentrations (Figure 2(C)) allows us calculating flavin association
and dissociation rate constants (kon and koff, respectively) and the
derived dissociation constants (Kd). The binding of the RFK
substrates–RF and ATP–is the fastest process (Table 2), and also
shows the largest fluorescence decay amplitude (Figure 2(A)).
Hence, contrary to that reported for CaFADS23, the SpnFADS RFK
site preferably binds the RF and ATP substrates over other
combinations of ligands, being the binding of the FMN product in
presence of the ATP substrate the least favored combination. In
addition, kobs2 values show that the conformational rearrangement
for flavin release is considerably faster when RF is the flavin ini-
tially bound (Figure 2(D)). Moreover, kobs2 shows a biphasic
behavior negatively affected by the FMN concentration, indicating
that accumulation of FMN hinders its release. Noticeable, kobs1 and
kobs2 for processes that involve RF and ATP are in the kcat range,
revealing that the reaction steps represented by these parameters
are relevant for catalysis. Nevertheless, as the kobs1/kobs2 ratio indi-
cates, the binding and the internalisation of the reaction sub-
strates is 4 times faster than the subsequent conformational
change that releases flavins to the solvent, being this last process
the SpnFADS RFK reaction bottleneck.
Considering our results in the context of those reported for the
RFK cycle of CaFADS, some key facts are worthy to be highlighted.
Both proteins require ANP nucleotides to bind/internalise flavin
ligands, and they show the same overall individual processes
along the reaction. Additionally, both FADSs are able to bind all
Figure 2. Pre-steady-state stopped-flow kinetics for RF and FMN binding to SpnFADS in the presence of adenine nucleotides. (A) Kinetic traces for the flavin fluores-
cence evolution upon mixing the protein with ANP-FLV combinations. (B) Example of fittings of kinetic traces. Evolution of (C) kobs1 and (D) kobs2 on FLV concentration,
with schemes representing the corresponding processes in the insets.
Table 2. Pre-steady-state kinetic parameters for flavins binding and dissociation
to SpnFADS in the presence of adenine nucleotides.
Ligands combination kon (min
1lM1) koff (min1) Kd (lM) DG (kcalmol1)
FMN-ADP 85 ± 7 65 ± 20 0.76 ± 0.24 8.3 ± 2.5
FMN-ATP a a
RF-ADP 102 ± 6b 84 ± 11b 0.83 ± 0.12 8.3 ± 1.4
RF-ATP 128 ± 14 73 ± 16 0.57 ± 0.14 8.5 ± 2.0
akobs1 values close to 0 prevented determination of kon and koff.
bValues obtained when [RF] 3lM. When [RF]	 3lM, kon
 297 ± 9 and koff
could not been determined.
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the possible combinations of ANP-FLV ligands, although differen-
ces in the relative binding rates and magnitude of the associated
spectroscopic changes must be behind the lower inhibition levels
shown by SpnFADS. Thus, while binding of the substrates of the
RFK reaction—that is RF and ATP—is the fastest and most favored
process for SpnFADS (Table 2), it is the slowest one for CaFADS23.
This fact together with a 10-times higher Ki
ADP, and a 9-times
higher Km
RF/Ki
FMN ratio for CaFADS than for SpnFADS, explains the
larger inhibition by the reaction products observed for CaFADS
(Table 1)23. Comparison of the kobs2 behavior for both enzymes
(Figure 2(D))23—kobs2 linearly depends on the RF concentration for
SpnFADS while it shows a biphasic behavior for CaFADS—shows
that during the CaFADS RFK reaction, high RF concentrations
inhibit the ATP-induced conformational change for flavin release,
while SpnFADS does not present such inhibition. This might be a
determinant of the strong inhibition by RF that CaFADS suf-
fers21,23, which is absent in SpnFADS.
Thermodynamics explain the modest inhibition of the SpnFADS
RFK activity
We next used ITC to determine whether the identified kinetic
processes were relevant to reach the thermodynamic equilibrium.
We titrated with the substrates and the products of the RFK reac-
tion, both free SpnFADS and its binary mixtures with either ANP or
FLV ligands. Since Mg2þ is necessary for the RFK reaction to occur,
we performed all titrations with and without this cation, to deter-
mine its role on ligands binding. However, titrations that involve
both reaction substrates only were executed without Mg2þ, since
the reaction heat would mask the binding enthalpy (Figure 3(A)).
Figure 3 illustrates all the possible binding pathways occurring
in the interaction landscape of the SpnFADS RFK module with the
substrates and products. As reported for CaFADS23, Mg2þ is key in
the formation of SpnFADS:ANP:FLV complexes (Figure 3 and
Supplementary Table SP1): (i) by increasing the protein fraction
prone to interact with a specific ligand, and consequently, the
probability of the pathway, and (ii) by favoring the formation of
ternary complexes from the binary ones (compare arrows thick-
ness and DG values in Figure 3(A,B)). The stabilisation of these
ternary complexes by Mg2þ is mainly a consequence of the less
unfavorable binding entropy (Supplementary Table SP1), which
suggests different conformations in ternary complexes with and
without MgCl2. It is worthy to highlight that although FLV binding
to the free protein is not directly observed by ITC or stopped-flow
spectrophotometry, flavins—particularly when Mg2þ is present—
highly modify the protein affinity for ANP ligands (Figure 3(B),
Supplementary Table SP1). This cooperative effect—also observed
with CaFADS23—evinces that RF and FMN act as slow-binding
ligands35. However, although their binding is too slow to be
measured within the experimental time, it can be indirectly
estimated27,28,36.
Titrations without MgCl2 (Figure 3(A)) allow establishing an
interaction diagram that includes “pseudo-reactive” pathways with
the reaction substrates (SpnFADS:ATP:RF). Comparison of this dia-
gram with that obtained for CaFADS23 reveals important differen-
ces, which might contribute to the regulatory dissimilarities
displayed between both proteins. Thus, (i) two alternative
Figure 3. Gibbs free energy diagrams for the interaction of SpnFADS with its ligands. Titrations performed (A) without MgCl2, and (B) with 0.8mM MgCl2. Numbers
indicate the DG value in kcal mol1. The arrows thickness is proportional to the protein fraction able to bind the ligand. NM denotes paths where the reaction heat
would mask the binding enthalpy.
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pathways lead to the SpnFADS:ATP:RF complexes, while CaFADS
presents only one pathway23 and (ii) SpnFADS:ATP:RF complexes
are almost the most stable ones—as their lowest position in the
DG diagram indicates—and also the most probable—thickest
orange arrows—. This situation is completely different for CaFADS,
where all the other non-productive CaFADS:ANP:FLV complexes
are favored against CaFADS:ATP:RF23.
We can extract two main conclusions from these results. First,
both proteins achieve the catalytic FADS:RF:ATP complex through
different mechanisms; SpnFADS seems to follow a random sequen-
tial binding of the RFK substrates, while CaFADS requires its con-
certed fit23. Second, as the RFK reaction progresses and the
products accumulate, pathways different from the reactive one are
favored in the case of CaFADS, which reduces the efficiency of the
overall catalysis23. For its part, the pathway that leads to
SpnFADS:ATP:RF is the most favored, at least until reaching a high
[products]/[substrates] ratio.
Conformational differences explain the dissimilar regulation of
prokaryotic RFK cycles
Structurally, the different mechanisms by which RF and ATP get
allocated in the RFK active site might be related to the simpler
conformational changes required by SpnFADS. Figure 4 shows the
relative conformation of the catalytic PTAN motif in SpnFADS
regarding CaFADS (Figure 4(B)) and CaFADS:FMN:ADP structures
(Figure 4(C)). Remarkably, the conformation of this motif in
SpnFADS resembles that of CaFADS in a ternary complex with the
products of the RFK reaction. So, the ligand-induced conforma-
tional change of this motif, which is crucial for the CaFADS RFK
cycle20, is not necessary for SpnFADS. This allows flexibility in the
allocation order of substrates in the SpnFADS RFK active site.
Figure 3 also reveals highly different DG values for titrations of
either free SpnFADS or of its binary complexes with the same
ligand, as well as that flavins are able to bind the enzyme in the
presence of ANP ligands but not in its absence. These effects can
be explained considering binding cooperative effects between
ANP and FLV ligands (Table 3), and slow binding of flavins to free
SpnFADS. Therefore, we carried out a co-operativity study that
again came out with fundamental differences regarding hetero-
tropic cooperativity in the CaFADS RFK module. Our data show
that for SpnFADS the RF and ATP substrates always show positive
cooperativity (Table 3). On the contrary, in the case of CaFADS low
RF concentrations facilitate ATP binding, while increasing RF
amounts hinder it23. This different cooperative behavior of the
substrates explains the inhibition by the RF substrate that CaFADS
shows but not SpnFADS. Structurally, such effect might be also
related to the different conformation of the PTAN motif. In
Figure 4. The C-terminal modules of CaFADS and SpnFADS. (A) Superposition of the RFK modules of SpnFADS (PDB 3OP1) and CaFADS (PDB 2X0K). Zoom into the con-
formation of the PTAN motif of SpnFADS and the corresponding residues in (B) CaFADS and (C) CaFADS:ADP:FMN (PDB 5A89).
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CaFADS, the occupation of the ANP binding site by RF —when it
is in excess— might prevent the ligand-induced conformational
change of this motif, which is necessary for ATP binding (Figure
4)23. This structural rearrangement is not necessary for SpnFADS
(Figure 4(B)), and therefore, the excess of RF does not hinder
ATP binding.
Collectively, our results shed light on the kinetic and thermo-
dynamic basis behind the substrates and products inhibition regu-
latory differences in the RFK cycles of SpnFADS and CaFADS.
These essential enzymes differ in the substrates binding order, as
well as in the inhibitory potency of the products and their action
mechanism. The lesser inhibition level presented by SpnFADS—
regarding CaFADS—is because of the binding of the reaction
substrates is the fastest and thermodynamically most favored pro-
cess, regardless of products accumulation. The structural origin of
such divergences is the dissimilar conformation that the key PTAN
motif shows in both FADSs, which points to species-specific
conformational changes during the RFK activity. This fact, together
with other differential regulatory strategies, such as the use of
reduced substrates, provide us with a broader frame in which we
could work in the development of new anti-microbials specific for
S. pneumoniae. That way, it might be feasible to envisage drugs
binding to a particular SpnFADS conformation, being unable to
interact–due to the structural constraints and functional differen-
ces–with other FADSs.
Conclusions
In conclusion, here we present a complete description of the RFK
catalytic cycle of SpnFADS, integrating thermodynamic and kinetic
data, both in the pre-steady and in the steady-state, obtained
using different biophysical and biochemical tools. We consider our
research highly relevant in a double way. On one hand, combining
physico-chemical tools commonly used in the biophysical charac-
terisation of proteins, we have designed a strategy to go beyond
the information directly extracted from this kind of techniques to
offer a model that contributes to explain the dynamics during the
SpnFADS RFK catalytic cycle. On the other hand, the results
derived from our study are also relevant for the scientific commu-
nity. Thus, we have found important differences between the RFK
catalytic cycles of two structurally similar essential proteins, i.e.
CaFADS and SpnFADS, shedding light on the thermodynamic and
kinetic determinants that led to these inhibitory differences.
Taking into account the pathogenic character of S. pneumoniae,
the essentiality of its FADS and the last tendencies in discovering
species-specific drugs, which reduce the resistances emergence,
the knowledge here presented might facilitate the development
of drugs able to bind a specific conformation of SpnFADS, having
no effect on other members of the FADS family.
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